The ROE as of April 2025 (TTM) for Clinuvel Pharmaceuticals Limited (CLVLY) is 18.45%

According to Clinuvel Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is 18.45%. This represents a change of 102.54% compared to the average of 9.11% of the last 4 quarters.

Clinuvel Pharmaceuticals Limited (CLVLY) Historical ROE (quarterly & annually)

How has CLVLY ROE performed in the past?

The mean historical ROE of Clinuvel Pharmaceuticals Limited over the last ten years is 8.43%. The current 18.45% ROE has changed 118.96% with respect to the historical average. Over the past ten years (40 quarters), CLVLY's ROE was at its highest in in the June 2018 quarter at 29.89%. The ROE was at its lowest in in the June 2005 quarter at -73.98%.

Clinuvel Pharmaceuticals Limited (CLVLY) ROE by Quarter and Year

Discovering the peaks and valleys of Clinuvel Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Clinuvel Pharmaceuticals Limited (CLVLY) Average ROE

How has CLVLY ROE performed in the past?

The current ROE of Clinuvel Pharmaceuticals Limited (CLVLY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Clinuvel Pharmaceuticals Limited (CLVLY) ROE vs. Peers

How is CLVLY’s ROE compared to its peers?

Clinuvel Pharmaceuticals Limited’s ROE is greater than GeoVax Labs, Inc. (-884.88%), greater than MediWound Ltd. (-113.56%), greater than Adial Pharmaceuticals, Inc. (-259.41%), greater than Insmed Incorporated (-1066.23%), less than BetterLife Pharma Inc. (0%), less than XORTX Therapeutics Inc. (46.88%), greater than Sigilon Therapeutics, Inc. (-24.61%), greater than Tango Therapeutics, Inc. (-74.73%), greater than CollPlant Biotechnologies Ltd. (-55.40%), greater than Keros Therapeutics, Inc. (-87.93%), greater than Merus N.V. (-37.86%), greater than Vericel Corporation (-35.19%), less than Century Therapeutics, Inc. (4.04%), greater than Aridis Pharmaceuticals, Inc. (-66.88%), less than Akari Therapeutics, Plc (160.39%), greater than Aditxt, Inc. (-956.20%), greater than ABVC BioPharma, Inc. (-458.10%), greater than Acasti Pharma Inc. (-75.73%), greater than null (-18.84%),

Build a custom stock screener for Clinuvel Pharmaceuticals Limited (CLVLY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clinuvel Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clinuvel Pharmaceuticals Limited (CLVLY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clinuvel Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.